Sekisui Chemical stock
4204.TJPXSekisui Chemical Co., Ltd., IndustrialsISIN JP3419400001
66Score 66 out of 100, Neutral
Price and trend
68 / 100
Price history
+3.6% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 3.8% above it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 59).
The price is 11% below its 52-week high. Largest decline in 20 years: 64% (February 2007 to October 2008).
Chart figures for advanced users
- SMA 50$16.07
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$16.34
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)59
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$14.15
- The lowest closing price of the last twelve months.
- Resistance$19.12
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Sekisui Chemical Co., Ltd. belongs to the Industrial (Specialties) industry (Japan) and, with a market value of $6.85B, is the largest of 5 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $8.2B (up 0.9% year on year) and earnings of $470.73M (down 8.2%).
- For fiscal 2027, analysts expect on average revenue of $9.05B (up 10.4%) and adjusted earnings per share of $1.20 (up 5%).
Show more
- MEQIRI Score 66 out of 100 (Neutral): rank 335 of 1018 in Industrials, median 61.
- The P/E is 14 (Industrials sector median 17, own median of recent years 13.4).
- Our model puts fair value at $25.10, with the price 32% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for 17 years.Capital allocation 75
- Below fair valuePrice 32% below the fair value of $25.10.Valuation 88
- Consistently profitableProfit in all 10 fiscal years from 2017 to 2026.Fundamentals 65
Weaknesses
- Negative free cash flowFree cash flow −$394.42M over the last 12 months.Fundamentals 65
Its standout strengths are stability and valuation, while growth holds the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 65 to 66.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly undervaluedClosing price of 12 Nov 2026, used by the daily score.
In our model the price counts as cheap below $20.92 and expensive above $31.37 (uncertainty low, based on the price swings of the past year).
The two parts of the fair value come to $29.62 (cash-flow model) and $20.58 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 6.2%. At 7.2% the fair value would be $22.46, at 5.2% it would be $29.05.
Valuation metrics
Half from the cash-flow model, half from earnings times the sector P/E (17).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 6.4% on the twelve months before. Revenue has stayed largely stable since 2007.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 32%, operating 8%, net 6%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 1 Feb 2027in 80 days
- Last reported
- 30 Oct 2026EPS reported $0.34 (expected $0.30)above expectations
Analyst estimates
Earnings estimates have barely changed since 27 Oct 2026.
- Earnings per share
- $1.20−2.6%
- Revenue
- $9.05B+1.4%
- Earnings per share
- $1.43−0.7%
- Revenue
- $9.55B+1.6%
MEQIRI has stored the estimates since 27 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Sekisui Chemical
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
1018 rated companies in Industrials
- This company
- 66
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Industrial (Specialties)
The next smaller companies by market value
All 5 Industrial (Specialties) stocksETFs that hold Sekisui Chemical
Held by 33 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| L&G Clean Water UCITS ETFXMLC | 1.83% | 0.49% | €588.71M |
| State Street SPDR S&P Pan Asia Dividend Aristocrats UCITS ETF (Dist)ZPRA | 0.48% | 0.55% | €225.69M |
| iShares MSCI Japan Small Cap UCITS ETFIUS4 | 0.47% | 0.58% | €548.59M |
Show 5 more
| WisdomTree Japan Equity UCITS ETF USD HedgedWTDX | 0.17% | 0.48% | €796.64M |
| Amundi Prime Japan UCITS ETF DR (D)PR1J | 0.11% | 0.05% | €4.34B |
| iShares Core MSCI Japan IMI UCITS ETFEUNN | 0.10% | 0.12% | €7.17B |
| Vanguard FTSE Japan UCITS ETF EUR Hedged AccumulatingVJPE | 0.09% | 0.13% | €4.58B |
| Amundi Japan TOPIX II UCITS ETF EUR DistLYY4 | 0.09% | 0.45% | €633.4M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 13 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 19 Sep 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
